1.86 -0.39 (-17.33%) | 05-21 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 3.6 | 1-year : | 4.82 |
Resists | First : | 3.08 | Second : | 4.12 |
Pivot price | 2.13 ![]() |
|||
Supports | First : | 1.4 | Second : | 1.16 |
MAs | MA(5) : | 2.23 ![]() |
MA(20) : | 2.2 ![]() |
MA(100) : | 2.11 ![]() |
MA(250) : | 6.95 ![]() |
|
MACD | MACD : | -0.1 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 27.9 ![]() |
D(3) : | 32 ![]() |
RSI | RSI(14): 44.5 ![]() |
|||
52-week | High : | 20.79 | Low : | 0.23 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ICCT ] has closed above bottom band by 24.2%. Bollinger Bands are 48.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 2.4 - 2.41 | 2.41 - 2.42 |
Low: | 2.21 - 2.22 | 2.22 - 2.23 |
Close: | 2.22 - 2.25 | 2.25 - 2.27 |
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.
Thu, 22 May 2025
iCoreConnect to be delisted from Nasdaq - Investing.com
Fri, 25 Apr 2025
iCoreConnect granted extension to meet NASDAQ listing standards - Investing.com
Mon, 21 Apr 2025
iCoreConnect faces Nasdaq delisting over late filing - Investing.com
Mon, 31 Mar 2025
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Wed, 26 Mar 2025
iCoreConnect faces potential asset auction by creditor - Investing.com
Wed, 26 Feb 2025
iCoreConnect Files Hearing Request With NASDAQ - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Healthcare Information Services
|
|
Shares Out | 0 (M) |
Shares Float | 2 (M) |
Held by Insiders | 856870 (%) |
Held by Institutions | 12.7 (%) |
Shares Short | 375 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.443e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | -263.2 % |
Operating Margin | -79 % |
Return on Assets (ttm) | -69.9 % |
Return on Equity (ttm) | -1 % |
Qtrly Rev. Growth | 1.105e+007 % |
Gross Profit (p.s.) | 36.2 |
Sales Per Share | 665.11 |
EBITDA (p.s.) | 7.93519e+006 |
Qtrly Earnings Growth | -63.3 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -8 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0.25 |
Dividend | 0 |
Forward Dividend | 351550 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |